IN192747B - - Google Patents

Info

Publication number: IN192747B
Authority: IN; India

Application number

Other languages

English (en)

Inventor

Manish Chawla

Rajeev Singh Raghuvanshi

Ashok Rampal

Original Assignee

Ranbaxy Lab Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-15

Filing date

2002-04-15

Publication date

2004-05-15

2002-04-15 Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd

2002-04-15 Priority to IN459DE2002 priority Critical patent/IN192747B/en

2003-04-15 Priority to EP03712530A priority patent/EP1499301A2/fr

2003-04-15 Priority to US10/511,486 priority patent/US20060165779A1/en

2003-04-15 Priority to BR0309298-4A priority patent/BR0309298A/pt

2003-04-15 Priority to PCT/IB2003/001416 priority patent/WO2003086362A2/fr

2003-04-15 Priority to AU2003216620A priority patent/AU2003216620A1/en

2003-04-15 Priority to CA002482646A priority patent/CA2482646A1/fr

2003-04-15 Priority to MXPA04010121A priority patent/MXPA04010121A/es

2004-05-15 Publication of IN192747B publication Critical patent/IN192747B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Emergency Medicine (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IN459DE2002 2002-04-15 2002-04-15 IN192747B (fr)

Priority Applications (8)

Application Number	Priority Date	Filing Date	Title
IN459DE2002 IN192747B (fr)	2002-04-15	2002-04-15
EP03712530A EP1499301A2 (fr)	2002-04-15	2003-04-15	Methode de stabilisation des comprimes d'hydrochlorure de bupropion
US10/511,486 US20060165779A1 (en)	2002-04-15	2003-04-15	Novel method stabilizing bupropion hydrochloride tablets
BR0309298-4A BR0309298A (pt)	2002-04-15	2003-04-15	Método para estabilizar comprimidos de cloreto de bupropion
PCT/IB2003/001416 WO2003086362A2 (fr)	2002-04-15	2003-04-15	Comprimes d'hydrochlorure de bupropion stables
AU2003216620A AU2003216620A1 (en)	2002-04-15	2003-04-15	Method of stabilizing bupropion hydrochloride tablets
CA002482646A CA2482646A1 (fr)	2002-04-15	2003-04-15	Comprimes d'hydrochlorure de bupropion stables
MXPA04010121A MXPA04010121A (es)	2002-04-15	2003-04-15	Un metodo para estabilizar tabletas de clorhidrato de bupropion.

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IN459DE2002 IN192747B (fr)	2002-04-15	2002-04-15

Publications (1)

Publication Number	Publication Date
IN192747B true IN192747B (fr)	2004-05-15

Family

ID=29227524

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN459DE2002 IN192747B (fr)	2002-04-15	2002-04-15

Country Status (8)

Country	Link
US (1)	US20060165779A1 (fr)
EP (1)	EP1499301A2 (fr)
AU (1)	AU2003216620A1 (fr)
BR (1)	BR0309298A (fr)
CA (1)	CA2482646A1 (fr)
IN (1)	IN192747B (fr)
MX (1)	MXPA04010121A (fr)
WO (1)	WO2003086362A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ME00391B (me)	2003-08-08	2011-10-10	Biovail Laboratories Int Srl	Tableta bupropion hidrohlorida sa modifikovanim otpuštanjem
WO2005049003A1 (fr) *	2003-11-21	2005-06-02	Ranbaxy Laboratories Limited	Formes pharmaceutiques a liberation prolongee de chlorhydrate de bupropion
ZA200711123B (en) *	2005-06-27	2009-08-26	Biovail Lab Int Srl	Modified-release formulations of a bupropion salt
US8703191B2 (en)	2006-07-25	2014-04-22	Intelgenx Corp.	Controlled-release pharmaceutical tablets
US7674479B2 (en)	2006-07-25	2010-03-09	Intelgenx Corp.	Sustained-release bupropion and bupropion/mecamylamine tablets
WO2008038155A2 (fr) *	2006-07-25	2008-04-03	Intelgenx Corp.	Comprimés pharmaceutiques à libération contrôlée
US20100055180A1 (en) *	2007-10-10	2010-03-04	Mallinckrodt Baker, Inc.	Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
CA2702055C (fr) *	2007-10-10	2017-12-12	Mallinckrodt Baker, Inc.	Excipient a base de cellulose microcristalline granulaire a fonctionnalite elevee directement compressible, son procede de fabrication et son utilisation
US10610528B2 (en)	2009-12-08	2020-04-07	Intelgenx Corp.	Solid oral film dosage forms and methods for making same
US20110136815A1 (en) *	2009-12-08	2011-06-09	Horst Zerbe	Solid oral film dosage forms and methods for making same
BR112013015213B1 (pt)	2010-12-16	2021-11-03	Merck Patent Gmbh	Uso de um meio de cultura de células seco granulado
US12109178B2 (en)	2013-11-05	2024-10-08	Antecip Bioventures Ii Llc	Bupropion as a modulator of drug activity
US11969421B2 (en)	2013-11-05	2024-04-30	Antecip Bioventures Ii Llc	Bupropion as a modulator of drug activity
US12194006B2 (en)	2013-11-05	2025-01-14	Antecip Bioventures Ii Llc	Bupropion as a modulator of drug activity
US11433067B2 (en)	2013-11-05	2022-09-06	Antecip Bioventures Ii Llc	Bupropion as a modulator of drug activity
WO2022119981A1 (fr)	2020-12-01	2022-06-09	Antecip Bioventures Ii Llc	Bupropion et dextrométhorphane pour la réduction du risque de suicide chez des patients dépressifs
US11717518B1 (en)	2022-06-30	2023-08-08	Antecip Bioventures Ii Llc	Bupropion dosage forms with reduced food and alcohol dosing effects
US12036191B1 (en)	2022-06-30	2024-07-16	Antecip Bioventures Ii Llc	Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan
US12156914B2 (en)	2022-06-30	2024-12-03	Axsome Therapeutics, Inc.	Pharmaceutical compositions comprising bupropion and cysteine
US11730706B1 (en)	2022-07-07	2023-08-22	Antecip Bioventures Ii Llc	Treatment of depression in certain patient populations
US12194036B2 (en)	2022-07-07	2025-01-14	Antecip Bioventures Ii Llc	Combination of dextromethorphan and bupropion for treating depression

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6033686A (en) *	1998-10-30	2000-03-07	Pharma Pass Llc	Controlled release tablet of bupropion hydrochloride
CA2259730A1 (fr) *	1999-01-18	2000-07-18	Bernard Charles Sherman	Pastilles a degagement prolonge contenant du chlorhydrate de bupropione
US6306436B1 (en) *	2000-04-28	2001-10-23	Teva Pharmaceuticals Usa, Inc.	Stabilized, acid-free formulation for sustained release of bupropion hydrochloride
ITMI20011457A1 (it) *	2001-07-09	2003-01-09	Valpharma Sa	Composizione farmaceutica a rilascio modificato contenente bupropionehc1 come sostanza attiva

2002
- 2002-04-15 IN IN459DE2002 patent/IN192747B/en unknown
2003
- 2003-04-15 WO PCT/IB2003/001416 patent/WO2003086362A2/fr not_active Application Discontinuation
- 2003-04-15 BR BR0309298-4A patent/BR0309298A/pt not_active Application Discontinuation
- 2003-04-15 US US10/511,486 patent/US20060165779A1/en not_active Abandoned
- 2003-04-15 AU AU2003216620A patent/AU2003216620A1/en not_active Abandoned
- 2003-04-15 MX MXPA04010121A patent/MXPA04010121A/es unknown
- 2003-04-15 CA CA002482646A patent/CA2482646A1/fr not_active Abandoned
- 2003-04-15 EP EP03712530A patent/EP1499301A2/fr not_active Withdrawn

Also Published As

Publication number	Publication date
WO2003086362A3 (fr)	2004-01-29
WO2003086362A2 (fr)	2003-10-23
US20060165779A1 (en)	2006-07-27
CA2482646A1 (fr)	2003-10-23
AU2003216620A8 (en)	2003-10-27
AU2003216620A1 (en)	2003-10-27
BR0309298A (pt)	2005-02-22
MXPA04010121A (es)	2004-12-13
EP1499301A2 (fr)	2005-01-26

Publication	Publication Date	Title
BE2019C547I2 (fr)	2022-05-17
BE2019C510I2 (fr)	2022-05-19
BE2018C021I2 (fr)	2023-03-07
BE2017C049I2 (fr)	2022-08-09
BE2017C005I2 (fr)	2022-05-17
BE2016C069I2 (fr)	2022-05-17
BE2016C040I2 (fr)	2022-05-17
BE2016C013I2 (fr)	2022-05-17
BE2015C078I2 (fr)	2022-08-09
BE2016C002I2 (fr)	2023-03-07
BE2018C018I2 (fr)	2023-03-07
BE2015C017I2 (fr)	2022-09-22
BE2014C053I2 (fr)	2022-08-30
BE2014C051I2 (fr)	2022-08-09
BE2014C041I2 (fr)	2022-08-09
BE2014C030I2 (fr)	2022-08-09
BE2014C016I2 (fr)	2023-03-07
BE2014C015I2 (fr)	2022-08-09
BE2013C063I2 (fr)	2023-03-07
BE2015C068I2 (fr)	2024-08-08
IN192747B (fr)	2004-05-15
JP2003107136A5 (fr)	2005-10-27
JP2003217643A5 (fr)	2005-07-21
JP2003142769A5 (fr)	2006-10-19
JP2003226219A5 (fr)	2006-10-05